About Biobeat
Biobeat is a company based in Petah Tikva (Israel) founded in 2014 by Johanan May. Biobeat has raised $51 million across 3 funding rounds from investors including European Union, Ally Bridge Group and Orbimed. Biobeat offers products and services including Cuff-less Blood Pressure Patch, In-Hospital Monitoring System, and Hospital at Home Solution. Biobeat operates in a competitive market with competitors including Withings, Ultrahuman, Tyto Care, iHealth Labs and Oura, among others.
- Headquarter Petah Tikva, Israel
- Founders Johanan May
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$51 M (USD)
in 3 rounds
-
Latest Funding Round
$50 M (USD), Series B
Dec 30, 2025
-
Investors
European Union
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biobeat
Biobeat offers a comprehensive portfolio of products and services, including Cuff-less Blood Pressure Patch, In-Hospital Monitoring System, and Hospital at Home Solution.
Wireless chest patch for continuous 24-hour blood pressure tracking and hypertension detection.
Integrated system for real-time vital signs monitoring in clinical settings.
Wireless tools for home-based blood pressure and health monitoring services.
People of Biobeat
Unlock access to complete
Funding Insights of Biobeat
Biobeat has successfully raised a total of $51M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $50 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biobeat
Biobeat has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Ally Bridge Group and Orbimed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Biobeat
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biobeat
Investment portfolio details for Biobeat
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biobeat
Detailed financials for Biobeat
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biobeat Comparisons
Peer comparison for Biobeat
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biobeat
Biobeat operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Withings, Ultrahuman, Tyto Care, iHealth Labs and Oura, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Connected devices for health, sleep, and activity monitoring are developed.
|
|
| Locked | Locked | Locked |
Metabolic health is tracked via devices and fitness platforms.
|
|
| Locked | Locked | Locked |
Medical consultations are facilitated via self-exams and remote diagnostic devices.
|
|
| Locked | Locked | Locked |
Personal healthcare devices for vital monitoring are designed and produced.
|
|
| Locked | Locked | Locked |
Health-tracking smart rings and biosensors are developed for biometric monitoring.
|
|
| Locked | Locked | Locked |
Medical devices for structural heart disease are developed and provided.
|
Detailed competitors of Biobeat
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biobeat
Complete news archive for Biobeat
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biobeat
Biobeat was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Biobeat is headquartered in Petah Tikva, Israel. It is registered at Petah Tikva, Central District, Israel.
Biobeat is a funded company, having raised a total of $51M across 3 funding rounds to date.
Biobeat offers a non-invasive body vitals monitoring wearable solution. It uses reflective Pulse Oximetry technology with their algorithm to allow for constant measurements of related body vitals. Sensor delivers a range of body vitals measurement including consciousness, saturation, pulse, temperature and perspiration. The devices are connected to a mobile app or a central monitoring system where the users data is stored. Data is then compared against a persons normal levels to identify life-threatening situations. It also allows data sharing with doctors and caregivers. They have released their products for athletes and Hospitals. Founded by Arik Ben Ishai Director of startups in the Rocket and Space Department of the Ministry of Defense, Israel.
Biobeat's top competitors include Withings, Ultrahuman and Oura.
Biobeat offers Cuff-less Blood Pressure Patch, In-Hospital Monitoring System, and Hospital at Home Solution.
Biobeat has 4 investors. Key investors include European Union, Ally Bridge Group, Orbimed, and Elevage Medical Technologies.